0 results for 'Merck'
Litigator of the (Past) Week Runners-Up
Yesterday morning we shouted out a bunch of impressive results that landed in that window from March 29 to April 5. This morning we're bringing you the Runners Up from that stretch.Federal Judge OKs Plaintiffs' Discovery Request for Adverse Event Reporting Data in Gardasil Case
In a crucial development this week in the ongoing multidistrict litigation against Merck & Co., a federal judge in North Carolina granted the plaintiffs' motion to compel adverse reaction data for the company's Gardasil HPV-vaccine, which faces challenges to both its safety and efficacy.Donald Flexner, Antitrust Titan of Boies Schiller Flexner, Dies at 81
During a legal career that spanned 55 years, Flexner helped break up AT&T while at the DOJ and went on to advise on the country's biggest mergers in private practice.Boots on the Ground or Hands on a Keyboard: Merck and Insurers Battle Out the War Exclusion
This article was originally posted on the Hunton Andrews Kurth Insurance Recovery Blog and is reprinted here with permission.With MDL Pending, LA-Based Personal Injury Firm Opposes California's Proposed HPV Vaccine Mandate
Los Angeles-based personal injury law firm Wisner Baum has come out in opposition to proposed legislation in California that, if passed, would add HPV vaccine Gardasil to the list of 10 required vaccinations for students attending public or private school in the state.View more book results for the query "Merck"
Antitrust Class Action Filed Against Merck for its Rotavirus Vaccine, RotaTeq
This suit was surfaced by Law.com Radar. Read the complaint here.Offer or Quote—Contract Question Remains the Source of Patent Peril
In Pfaff v. Wells Electronics, 525 U.S. 55 (1998), the U.S. Supreme Court articulated a two-prong test, holding the on-sale bar applies when, before the critical date (one year prior to the filing date of a patent application), the claimed invention was the subject of a commercial offer for sale and ready for patenting.'Unexplained Large Reverse Payment': Zetia Antitrust Claims Scheduled for Jury Trial in April
Plaintiffs claimed the two companies "conspired to delay the introduction of generic ezetimibe to the market, in violation of Sections 1 and 2 of the Sherman Act."Dan Weiner of Hughes Hubbard & Reed on the Benefits of 'Deep Industry Focus'
"As the saying goes, 'A little knowledge is a dangerous thing'; we pride ourselves in knowing both the law and the subject matter of our cases, inside and out."Playing the 'Long Game,' Goodwin's Profits Drop 6% Even as Revenue Rises Double Digits
Speaking shortly after the firm's layoffs, chair Robert Insolia said Goodwin's size is now appropriate for the amount of work it has, and the firm remains committed to long-term growth over short-term results.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates
Brought to you by LexisNexis® CounselLink®
Download Now
AI in Private Equity: A Guide for Gaining an Early Advantage
Brought to you by Ontra
Download Now
Why Are So Many Law Firms Suddenly Embracing Digital Transformation?
Brought to you by AllRize
Download Now
2025 State Legislative Sessions
Brought to you by LexisNexis®
Download Now